Proportion of Acute Leukemia Patients With Cells in CD34 Subset Fractions
| % of Cells . | CD34+ . | CD34+/71− . | CD34+/38− . | CD34+/Thy-1+ . |
|---|---|---|---|---|
| in Subfraction . | (%) . | (%) . | (%) . | (%) . |
| AML patients | ||||
| 15-100 | 25/52 (48) | 9/48 (19) | 3/50 (6) | 0/52 (0) |
| 5-15 | 7/52 (13) | 10/48 (21) | 7/50 (14) | 1/52 (2) |
| 1-5 | 9/52 (17) | 8/48 (17) | 12/50 (24) | 2/52 (4) |
| <1 | 11/52 (21) | 21/48 (44) | 28/50 (56) | 49/52 (94) |
| ALL patients | ||||
| 15-100 | 8/11 (73) | 5/10 (50) | 0/11 (0) | 2/11 (18) |
| 5-15 | 1/11 (9) | 1/10 (10) | 1/11 (9) | 0/11 (0) |
| 1-5 | 2/11 (18) | 3/10 (30) | 9/11 (82) | 3/11 (27) |
| <1 | 0 (0) | 1/10 (10) | 1/11 (9) | 6/11 (54) |
| % of Cells . | CD34+ . | CD34+/71− . | CD34+/38− . | CD34+/Thy-1+ . |
|---|---|---|---|---|
| in Subfraction . | (%) . | (%) . | (%) . | (%) . |
| AML patients | ||||
| 15-100 | 25/52 (48) | 9/48 (19) | 3/50 (6) | 0/52 (0) |
| 5-15 | 7/52 (13) | 10/48 (21) | 7/50 (14) | 1/52 (2) |
| 1-5 | 9/52 (17) | 8/48 (17) | 12/50 (24) | 2/52 (4) |
| <1 | 11/52 (21) | 21/48 (44) | 28/50 (56) | 49/52 (94) |
| ALL patients | ||||
| 15-100 | 8/11 (73) | 5/10 (50) | 0/11 (0) | 2/11 (18) |
| 5-15 | 1/11 (9) | 1/10 (10) | 1/11 (9) | 0/11 (0) |
| 1-5 | 2/11 (18) | 3/10 (30) | 9/11 (82) | 3/11 (27) |
| <1 | 0 (0) | 1/10 (10) | 1/11 (9) | 6/11 (54) |